Endaural phonoelectrophoresis with dexamethasone in the treatment of Meniere’s disease

Kunelskaya N.L.; Mishchenko V.V.

doi:https://doi.org/10.17116/otorino20259006119

Kunelskaya N.L.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-1001-2609

Mishchenko V.V.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-6352-2223

Endaural phonoelectrophoresis with dexamethasone in the treatment of Meniere’s disease

Authors:

Kunelskaya N.L., Mishchenko V.V.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2025;90(6): 19‑23

DOI: 10.17116/otorino20259006119

Read: 503 times

Contact the author

Table of contents

To cite this article:

Kunelskaya NL, Mishchenko VV. Endaural phonoelectrophoresis with dexamethasone in the treatment of Meniere’s disease. Russian Bulletin of Otorhinolaryngology. 2025;90(6):19‑23. (In Russ.)
https://doi.org/10.17116/otorino20259006119

Подписка 2026 Вестник оториноларингологии (Russian Bulletin of Otorhinolaryngology)

Использование инфографики авторами научных работ

Recommended articles:

Diagnosis of labyrinth hydrops in patients on different stages of Meniere’s disease. Russian Bulletin of Otorhinolaryngology. 2025;(3):24-29

Efficiency of pharmacophysical effects in patients with subjective tinnitus due to chronic sensorineural hearing loss. Russian Bulletin of Otorhinolaryngology. 2025;(6):24-28

Role of platelet-rich plasma in management of sensorineural hearing loss diseases. Russian Bulletin of Otorhinolaryngology. 2026;(1):4-10

Abstract:

The results of endaural phonoelectrophoresis with dexamethasone in 63 patients with Meniere’s disease are presented. Significant and satisfactory clinical effect was achieved in 76% of cases (38% in each group). The greatest therapeutic effect is predicted during the first 5 years of the disease, as well as with I and II degrees of hearing loss, a greater number of physiotherapeutic procedures (optimally 7—10). In case of achieving a decrease in hearing thresholds in dynamics, as well as a decrease in the resonant frequency of the middle ear, the effect of the therapy is maintained for at least 3 months.

Keywords:

Meniere’s disease

chronic sensorineural hearing loss

endaural phonoelectrophoresis

dexamethasone

Authors:

Kunelskaya N.L.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-1001-2609

Mishchenko V.V.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-6352-2223

Received:

21.05.2025

Accepted:

19.06.2025

Close metadata

References:

Kunelskaya NL, Diab HM, Popadyuk VI, Garov EV, Kuzovkov VE, Zaytseva OV, Machalov AS, Lilenko SV, Levina YuV, Savelyeva EE. Bolezn’ Men’era. Klinicheskie rekomendatsii. 2024. (In Russ.). Accessed September 20, 2025. https://zaoneuro75.ru/wp-content/uploads/2024/09/Bolezn-Menera.pdf
Kryukov AI, Kunelskaya NL, Garov EV, Stepanova EA, Sudarev PA, Yanyushkina ES, Abramenko AS, Sharova EE, Larionova EV. The effectiveness of transtympanic use of dexamethasone 4 mg in Meniere’s disease, severe and moderate course of the disease. Russian Bulletin of Otorhinolaryngology. 2022;87(1):21-26. (In Russ.). https://doi.org/10.17116/otorino20228701121
Farhood Z, Lambert PR. The physiologic role of corticosteroids in Meniere’s disease. American Journal of Otolaryngology — Head and Neck Medicine and Surgery. 2016;37(5):455-458. https://doi.org/10.1016/j.amjoto.2016.04.004
Li S, Ilmari P, Zhang Q, Yang J, Duan M. Consensus on intratympanic drug delivery for Menière’s disease. European Archives of Oto-Rhino-Laryngology. 2022;279(8):3795-3799. https://doi.org/10.1007/s00405-022-07374-y
Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V. International consensus (ICON) on treatment of Ménière’s disease. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2018;135(1):29-32. https://doi.org/10.1016/j.anorl.2017.12.006
Webster KE, Lee A, Galbraith K, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, Ray J, Van Vugt VA, Westerberg B, Burton MJ. Intratympanic corticosteroids for Ménière’s disease. Cochrane Database of Systematic Reviews. 2023;2:CD015245. https://doi.org/10.1002/14651858.CD015245.pub2
Salt AN, Plontke SK. Steroid nomenclature in inner ear therapy. Otology and Neurotology. 2020;41(6):722-726. https://doi.org/10.1097/MAO.0000000000002624
Magnan J, Ozgirgin ON, Trabalzini F, Lacour M, Escamez AL, Magnusson M, Guneri EA, Guyot JP, Nuti D, Mandala M. European position statement on diagnosis, and treatment of Meniere,s disease. The Journal of International Advanced Otology. 2018;14(2):317-321. https://doi.org/10.5152/iao.2018.140818
Bird PA, Murray DP, Zhang M, Begg EJ. Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otology and Neurotology. 2011;32(6):933-936. https://doi.org/10.1097/MAO.0b013e3182255933
Rarey KE, Curtis LM. Receptors for glucocorticoids in the human inner ear. Otolaryngology — Head and Neck Surgery. 1996; 115(1):38-41. https://doi.org/10.1016/S0194-5998(96)70133-X
Nevoux J, Viengchareun S, Lema I, Lecoq A-L, Ferrary E, Lombes M. Glucocorticoids stimulate endolymphatic water reabsorption in inner ear through aquaporin 3 regulation. Pflügers Archiv European Journal of Physiology. 2015;467(9):1931-1943. https://doi.org/10.1007/s00424-014-1629-5
Kunelskaya NL, Garov EV, Garova EE, Yanyushkina ES, Nikitkina YaYu, Manaenkova EA, Pryahina MA, Kovtun OV. Glucocorticosteroids in the treatment of acute neurosensory hearing loss. The current state of the problem. Part 2. Russian Bulletin of Otorhinolaryngology. 2022;87(5):70-74. (In Russ.). https://doi.org/10.17116/otorino20228705170
Chandrasekhar SS, Tsai Do BS, Schwartz SR, Bontempo LJ, Faucett EA, Finestone SA, Hollingsworth DB, Kelley DM, Kmucha ST, Moonis G, Poling GL, Roberts JK, Stachler RJ, Zeitler DM, Corrigan MD, Nnacheta LC, Satterfield L. Clinical Practice Guideline: Sudden Hearing Loss (Update). Otolaryngology — Head and Neck Surgery. 2019;161(1S):S1-S45. https://doi.org/10.1177/0194599819859885
Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A; Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS); Korean Balance Society. Diagnostic criteria for Menière’s disease. Journal of Vestibular Research. 2015;25(1):1-7. https://doi.org/10.3233/VES-150549
Kryukov AI. Razrabotka farmakofizicheskikh vozdejstvij na slukhovoj retseptor pri nejrosensornoj tugoukhosti: Diss. … kand. med. nauk. M. 1988. (In Russ.).
Patent RF na izobretenie RU2810441C1/27.12.2023. Leushin VYu, Gudkov AG, Sidorov IA, Kryukov AI, Kunelskaya NL, Mishchenko VV, Yanyushkina ES. Apparat dlya lecheniya nejrosensornoj tugoukhosti metodom endaural’nogo fonoelektroforeza. (In Russ.).
Kryukov AI, Kunelskaya NL, Garov EV, Belyakova LV, Baybakova EV, Yanyushkina ES, Zagorskaya EE, Levina Yu V, Guseva AL, Chugunova MV, Kudeeva YaYu, Karneeva OV, Kirichenko IM. Bolezn’ Men’era. Klinicheskie rekomendatsii. M.—SPb; 2014. (In Russ.).
Krotov SYu, Ignat’ev YuT, Krotov YuA. Tympanic cavity ultraphonophoresis in cases of preserving integrity of tympanic membrane. Russian Otorhinolaryngology. 2021;20(1):51-55. https://doi.org/10.18692/1810-4800-2021-1-51-55